The FDA is encouraging new complex trial designs that are adaptive and/or Bayesian. This page describes a program where drug companies are encouraged to propose these designs and they publicly disclose the details so that others can learn from their successes (and failures).

U.S. Food and Drug Administration. Complex Innovative Trial Designs Pilot Program. Available in html format.

This Recommendation was added to the website on 2018-09-13 and was last modified on 2020-02-29. You can find similar pages at Research design.

An earlier version of this page appears here.